Ocular Therapeutix, Inc.
OCULDrugs in Pipeline
15
Phase 3 Programs
9
Upcoming Catalysts
5
Next Catalyst
Jun 17, 2026
5wMarket Overview
Stock performance and key metrics
5 upcoming, 3 past
Aflibercept
Neovascular Age-related Macular Degeneration
OTX-TKI (axitinib implant)
Neovascular Age-Related Macular Degeneration
Single intravitreal injection of axitinib hydrogel implant followed by a mock (sham) injection procedure at Week 24
Non-Proliferative Diabetic Retinopathy
Ophthalmic Insert
Open Angle Glaucoma and Ocular Hypertension
Dextenza Ophthalmic Insert
Cataract
Travoprost
Open Angle Glaucoma
Dexamethasone, 0.4mg
Allergic Conjunctivitis
Dexamethasone
Post-Surgical Ocular Pain
Punctum Plug
Post Ocular Surgical Inflammation and Pain
OTX-TP
Glaucoma
OTX-TIC low dose Travoprost Intracameral Implant
Open Angle Glaucoma
OTX-CSI
Dry Eye Disease
OTX-DED
Dry Eye
OTX-DP (Dexamethasone punctum plug)
Ocular Inflammation and Pain
Controlled Insertion
Dry Eye Syndromes
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Aflibercept | Phase 3 | Neovascular Age-related Macular Degeneration | - | - |
OTX-TKI (axitinib implant) | Phase 3 | Neovascular Age-Related Macular Degeneration | - | - |
Single intravitreal injection of axitinib hydrogel implant followed by a mock (sham) injection procedure at Week 24 | Phase 3 | Non-Proliferative Diabetic Retinopathy | - | - |
Ophthalmic Insert | Phase 3 | Open Angle Glaucoma and Ocular Hypertension | - | - |
Dextenza Ophthalmic Insert | Phase 3 | Cataract | - | - |
Travoprost | Phase 3 | Open Angle Glaucoma | - | - |
Dexamethasone, 0.4mg | Phase 3 | Allergic Conjunctivitis | - | - |
Dexamethasone | Phase 3 | Post-Surgical Ocular Pain | - | - |
Punctum Plug | Phase 3 | Post Ocular Surgical Inflammation and Pain | - | - |
OTX-TP | Phase 2 | Glaucoma | - | - |
OTX-TIC low dose Travoprost Intracameral Implant | Phase 2 | Open Angle Glaucoma | - | - |
OTX-CSI | Phase 2 | Dry Eye Disease | - | - |
OTX-DED | Phase 2 | Dry Eye | - | - |
OTX-DP (Dexamethasone punctum plug) | Phase 2 | Ocular Inflammation and Pain | - | - |
Controlled Insertion | Phase 2 | Dry Eye Syndromes | - | - |